Jin Zi-Bing, Mandai Michiko, Homma Kohei, Ishigami Chie, Hirami Yasuhiko, Nao-I Nobuhisa, Takahashi Masayo
Laboratory for Retinal Regeneration, RIKEN Center for Developmental Biology, Kobe, Hyogo, Japan.
Invest Ophthalmol Vis Sci. 2008 Sep;49(9):3799-805. doi: 10.1167/iovs.07-1656. Epub 2008 Apr 30.
Allelic copy number variation (CNV) may alter the functional effects of a heterozygous mutation. The underlying mechanisms and their roles in hereditary diseases, however, are largely unknown. In the present study an FSCN2 mutation was examined that has been reported, not only in patients with retinitis pigmentosa (RP), but also in the normal population.
Experiments were performed to investigate the gene and allele copy numbers of FSCN2 in patients with RP who have the c.72delG mutation as well as healthy subjects with or without the mutation. A real-time PCR-based genotyping approach was established that used a real-time PCR assay to qualify the copy numbers of both the wild-type and mutant alleles of the FSCN2 gene.
Three patients with RP and three normal subjects had an equal ratio of the alleles. Of interest, another patient had an asymmetric allele ratio (4:1) of the copy number of the wild-type allele, compared with that of the mutant allele. These findings were further verified using quantitative assays. An allele-specific methylation assay demonstrated a random methylation pattern in the FSCN2 gene.
The copy numbers of the FSNC2 gene and of each allele in the mutant samples were quantified. The findings excluded the possibility that allelic CNV was associated with RP, suggesting that the c.72delG variant is not the primary cause of RP. It is not likely that the FSCN2 gene is imprinted differentially. The real-time PCR-based genotyping method developed in this study is useful for investigations of allelic asymmetries within genomic regions with CNVs.
等位基因拷贝数变异(CNV)可能会改变杂合突变的功能效应。然而,其潜在机制及其在遗传性疾病中的作用在很大程度上尚不清楚。在本研究中,对一个FSCN2突变进行了检测,该突变不仅在视网膜色素变性(RP)患者中被报道,在正常人群中也有发现。
对携带c.72delG突变的RP患者以及有或无该突变的健康受试者进行实验,以研究FSCN2的基因和等位基因拷贝数。建立了一种基于实时PCR的基因分型方法,该方法使用实时PCR测定法来确定FSCN2基因野生型和突变等位基因的拷贝数。
3例RP患者和3例正常受试者的等位基因比例相等。有趣的是,另一名患者野生型等位基因拷贝数与突变等位基因的比例呈不对称(4:1)。这些发现通过定量分析得到进一步验证。等位基因特异性甲基化分析显示FSCN2基因存在随机甲基化模式。
对突变样本中FSNC2基因及其每个等位基因的拷贝数进行了定量。研究结果排除了等位基因CNV与RP相关的可能性,表明c.72delG变异不是RP的主要原因。FSCN2基因不太可能存在差异印记。本研究开发的基于实时PCR的基因分型方法可用于研究具有CNV的基因组区域内的等位基因不对称性。